Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing.
暂无分享,去创建一个
Yanqing Wang | Yu-xiang Fang | H. Zhu | Wei-Qiang Gao | Na An | Wei-Qiang Gao | Lian-Zi Wei | Yan-Qing Wang | Yun-Li Chang | Na An | Xiao Wang | Pei-Jie Zhou | Helen He Zhu | Yu-Xiang Fang | Pei-Jie Zhou | Xiao Wang | Lianzi Wei | Yunli Chang
[1] M. Ittmann,et al. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer , 2014, The Prostate.
[2] Q. Wei,et al. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. , 2015, European journal of cancer.
[3] R. Shiekhattar,et al. The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.
[4] Juanjuan Zhao,et al. MicroRNA-7: a promising new target in cancer therapy , 2015, Cancer Cell International.
[5] R. Place,et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. , 2010, Cancer research.
[6] Chen-Chung Lin,et al. A KLF4–miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context , 2011, Molecular and Cellular Biology.
[7] Min Gyu Lee,et al. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness , 2016, Nucleic acids research.
[8] A. Krainer,et al. A splicing-independent function of SF2/ASF in microRNA processing. , 2010, Molecular cell.
[9] Paul C. Boutros,et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER , 2014, Nature Communications.
[10] Wei-Qiang Gao,et al. Regulation and Methylation of Tumor Suppressor MiR-124 by Androgen Receptor in Prostate Cancer Cells , 2015, PloS one.
[11] Z. Ji,et al. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway , 2015, Oncotarget.
[12] D. Peeper,et al. KLF4, p21 and context-dependent opposing forces in cancer , 2006, Nature Reviews Cancer.
[13] T. Tomasi,et al. The modulation of Dicer regulates tumor immunogenicity in melanoma , 2016, Oncotarget.
[14] An-Yuan Guo,et al. MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia , 2012, Nucleic acids research.
[15] W. Foulkes,et al. DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.
[16] C. Thomssen,et al. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family , 2016, Nucleic acids research.
[17] Qin Chen,et al. SUMOylation at K707 of DGCR8 controls direct function of primary microRNA , 2015, Nucleic acids research.
[18] Qi Li,et al. Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4 , 2016, Oncotarget.
[19] G. Calin,et al. Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression , 2014, Nature Communications.
[20] Toru Suzuki,et al. miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation. , 2015, Journal of molecular and cellular cardiology.
[21] Dong Hu,et al. Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition , 2011, Molecular and Cellular Biology.
[22] F. Camargo,et al. Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer , 2014, Cell.
[23] Y. Mo,et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. , 2013, Cancer research.
[24] Ling Tian,et al. MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma , 2012, Hepatology.
[25] Xin-Yu Na,et al. Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. , 2015, International journal of clinical and experimental medicine.
[26] Jing Wang,et al. MiR‐7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway , 2014, Stem cells.
[27] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[28] Yi Ma,et al. Consent for Use of Clinical Leftover Biosample: A Survey among Chinese Patients and the General Public , 2012, PloS one.
[29] C. Norbury,et al. The Long and Short of MicroRNA , 2013, Cell.
[30] Yang Liu,et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma. , 2009, Carcinogenesis.
[31] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[32] K. Ohshiro,et al. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. , 2008, Cancer research.